{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:09:34Z","timestamp":1772521774848,"version":"3.50.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Variant Creutzfeldt\u2013Jakob disease (vCJD) is a fatal transmissible prion disorder attributed primarily to the ingestion of meat from cattle infected with bovine spongiform encephalopathy (BSE), and it can also be transmitted through blood transfusions and occupational exposure in laboratories. As of July 2024, 233 deaths had been recorded in 12 countries, mostly in the United Kingdom (UK) and France.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to describe the results of vCJD surveillance in Spain from 1993 to 2021 and the responses to those results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Surveillance spanned the following three periods: 1993\u20132000, when neurologists and public health professionals created a network for reporting potential cases; 2001\u20132010, when diagnostic criteria were improved, and management guidelines were published; and 2011\u20132021, when reporting and post-mortem analyses decreased.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five deaths due to vCJD were identified through post-mortem between 2005 and 2008 (ages ranging from 25 to 64 years). In two cases involving a mother and her son, their prion strain was similar to the strain found in UK humanized mouse models, suggesting a link to BSE. Three cases had recently undergone invasive dental procedures, one had undergone a fibroscopy, and another had donated blood several times. The majority of prevention measures were adopted with a delay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Spain is the third most affected country by vCJD. Interruption of beef imports from the UK and control of the local BSE epizootic may have helped control vCJD in Spain since 2009. The increase in vCJD deaths through occupational exposures in laboratory work in other countries since 2016 should act as a warning signal for the surveillance of all forms of human transmissible spongiform encephalopathies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1780793","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:48:01Z","timestamp":1772520481000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Variant Creutzfeldt\u2013Jakob disease surveillance in Spain, 1993\u20132021"],"prefix":"10.3389","volume":"14","author":[{"given":"Jes\u00fas","family":"De Pedro-Cuesta","sequence":"first","affiliation":[{"name":"Department of Neurodegeneration, Mental Health and Ageing, National Epidemiology Centre, Carlos III Health Institute (ISCIII)","place":["Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando J.","family":"Garc\u00eda L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration, Mental Health and Ageing, National Epidemiology Centre, Carlos III Health Institute (ISCIII)","place":["Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Calero","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration, Mental Health and Ageing, National Epidemiology Centre, Carlos III Health Institute (ISCIII)","place":["Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Ruiz-Tovar","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration, Mental Health and Ageing, National Epidemiology Centre, Carlos III Health Institute (ISCIII)","place":["Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Almaz\u00e1n-Isla","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration, Mental Health and Ageing, National Epidemiology Centre, Carlos III Health Institute (ISCIII)","place":["Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt-Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet."},{"key":"B2","first-page":"8","article-title":"National archives. The BSE inquiry: the report","volume":"8","year":"2020","journal-title":"Variant CJD."},{"key":"B3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/19336896.2021.1933873","article-title":"Human prion disease surveillance in Spain, 1993-2018: an overview","volume":"15","author":"de Pedro-Cuesta","year":"2021","journal-title":"Prion."},{"key":"B4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4161\/pri.29237","article-title":"Variant CJD","volume":"8","author":"Diack","year":"2014","journal-title":"Prion."},{"key":"B5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/B978-0-444-63945-5.00011-8","article-title":"Variant Creutzfeldt-Jakob disease","volume":"153","author":"Brandel","year":"2018","journal-title":"Handb Clin Neurol."},{"key":"B6","unstructured":"Research & Surveillance Unit (NCJDRSU). Variant CJD Cases Worldwide\n          \n          2022"},{"key":"B7","doi-asserted-by":"publisher","first-page":"f5675","DOI":"10.1136\/bmj.f5675","article-title":"Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey","volume":"347","author":"Gill","year":"2013","journal-title":"BMJ."},{"key":"B8","unstructured":"Variant Creutzfeldt-Jakob Disease. Annual Epidemiology Report for 2021\n          \n          2021"},{"key":"B9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ana.21583","article-title":"Variant Creutzfeldt-Jakob disease in France and the United Kingdom: evidence for the same agent strain","volume":"65","author":"Brandel","year":"2009","journal-title":"Ann Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/jnnp.2010.232074","article-title":"Variant Creutzfeldt-Jakob disease occurring in mother and son","volume":"83","author":"Riverol","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B11","unstructured":"European Creutzfeldt-Jakob Disease Surveillance Network (EuroCJD)\n          \n          2021"},{"key":"B12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/1471-2458-6-278","article-title":"Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002","volume":"6","author":"de Pedro-Cuesta","year":"2006","journal-title":"BMC Public Health."},{"key":"B13","first-page":"77","article-title":"Encefalopat\u00edas espongiformes transmisibles humanas en Espa\u00f1a","volume":"18","author":"Almaz\u00e1n","year":"2010","journal-title":"Bolet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/1531-8249(200005)47:5<575::AID-ANA4>3.0.CO;2-W","article-title":"Diagnosis of new variant Creutzfeldt-Jakob disease","volume":"47","author":"Will","year":"2000","journal-title":"Ann Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/ana.21987","article-title":"Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease","volume":"67","author":"Heath","year":"2010","journal-title":"Ann Neurol."},{"key":"B16","first-page":"277","article-title":"Variante de la enfermedad de Creutzfeldt-Jakob en Espa\u00f1a, 1993-2003","volume":"10","author":"Grupo","year":"2002","journal-title":"Bolet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain."},{"key":"B18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/386232a0","article-title":"Typing prion isoforms","volume":"386","author":"Parchi","year":"1997","journal-title":"Nature."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3201\/eid2309.170159","article-title":"Similarities of variant Creutzfeldt-Jakob disease strain in mother and son in Spain to UK reference case","volume":"23","author":"Diack","year":"2017","journal-title":"Emerg Infect Dis."},{"key":"B20","unstructured":"Surveillance of CJD in the UK"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2807\/ese.17.15.20144-en","article-title":"Health professions and risk of sporadic Creutzfeldt-Jakob disease, 1965 to 2010","author":"Alcalde-Cabero","year":"2012","journal-title":"Euro Surveill"},{"key":"B22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1741-7015-5-24","article-title":"Jr","volume":"5","author":"Perry","year":"2007","journal-title":"BMC Med."},{"key":"B23","unstructured":"Recomendaciones de la Comisi\u00f3n Nacional de Hemoterapia respecto a las EETH\n          \n          \n            \n              Consejo\n              Interterritorial del Sistema Nacional de Salud\n            \n          \n          En Enfermedad de Creutzfeldt-Jakob y otras encefalopat\n          \n          2003"},{"key":"B24","unstructured":"Avellanal\n              F\n            \n            \n              Almaz\u00e1n\n              J\n            \n            \n              Calero\n              M\n            \n            \n              Mahillo\n              I\n            \n            \n              Mart\u00ednez\n              P\n            \n            \n              De Pedro\n              J\n            \n          \n          Encefalopat\n          \n          2006"},{"key":"B25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/jnnp.2007.128389","article-title":"Variant Creutzfeldt-Jakob [corrected] disease: the second case in Portugal and in the same geographical region","volume":"79","author":"Machado","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/vr.151.17.509","article-title":"Description of the first cases of BSE in Spain","volume":"151","author":"Badiola","year":"2002","journal-title":"Vet Rec."},{"key":"B27","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s00415-006-0360-3","article-title":"The first case of variant Creutzfeldt-Jakob disease in the Netherlands","volume":"254","author":"S\u00e1nchez-Juan","year":"2007","journal-title":"J Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3201\/eid1308.070178","article-title":"Source of variant Creutzfeldt-Jakob disease outside United Kingdom","volume":"13","author":"Sanchez-Juan","year":"2007","journal-title":"Emerg Infect Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.vetmic.2011.07.023","article-title":"Epidemiological indication for a role of sheep in the emergence of variant Creutzfeldt-Jakob disease","volume":"154","author":"Juste","year":"2012","journal-title":"Vet Microbiol."},{"key":"B30","unstructured":"Stockholm\n          ECDC\n          Review of Guidelines for Prevention of Creutzfeldt\u2013Jakob Disease Transmission in Medical Settings in EU Member States and Norway\n          \n          2011"},{"key":"B31","unstructured":"Surveillance Atlas of Infectious Diseases. Creutzfeldt-Jakob Disease, Variant\n          \n          2024"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1780793\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:48:19Z","timestamp":1772520499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1780793\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":31,"alternative-id":["10.3389\/fpubh.2026.1780793"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1780793","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"article-number":"1780793"}}